DNTH: Dianthus Therapeutics, Inc. Stock

by  •  • Comments Off on DNTH: Dianthus Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 683.62
Enterprise Value ($M) 660.83
Book Value ($M) 352.48
Book Value / Share 10.97
Price / Book 1.94
NCAV ($M) 259.37
NCAV / Share 8.07
Price / NCAV 2.64

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 15.06
Current Ratio 15.22

Balance Sheet (mrq) ($M)
Current Assets 280.90
Assets 374.01
Liabilities 21.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.24
Operating Income -101.86
Net Income -84.97
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -78.18
Cash from Investing -286.81
Cash from Financing 255.62

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Ra Capital Management, L.p. 9.40 -4.28
02-14 13G/A BCLS Fund III Investments, LP 8.80 -10.10
02-05 13G/A Octagon Capital Advisors LP 7.10 20.81
12-03 13D/A Avidity Partners Management LP 9.90 0.25
11-22 13G TCG Crossover GP II, LLC 5.10
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 5.90 88.03
11-14 13G/A 5AM Partners VII, LLC 3.50 -38.92
11-08 13G BlackRock, Inc. 5.60 0.00
09-12 13D/A Viridian, LLC 3.72 0.00
04-01 13D/A Fairmount Funds Management LLC 9.99 -0.11
2024-02-14 13G/A Third Rock Ventures IV, L.P. 0.00
2024-02-14 13G/A Citadel Advisors Llc 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 45,450 149,126 30.48
2025-03-13 80,258 223,040 35.98
2025-03-12 42,652 210,726 20.24
2025-03-11 57,157 271,651 21.04
2025-03-10 66,405 197,861 33.56

(click for more detail)

Similar Companies
DARE – Daré Bioscience, Inc. DERM – Journey Medical Corporation
DMAC – DiaMedica Therapeutics Inc. DRMA – Dermata Therapeutics, Inc.
DRRX – DURECT Corporation


Financial data and stock pages provided by
Fintel.io